GlassScriptPhysician profile
Pankaj C Gupta
NPI 1609929371
$3,728.42
in general payments reported to CMS, 2019-2025
26 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2022: $134 · 2023: $671 · 2024: $1,329 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,296 · Entertainment: $33.36 · Gift: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,296.45 |
| Entertainment | $33.36 |
| Gift | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.01 | 2022-2025 | |
| Alcon Vision LLC | $564.83 | 2023-2025 | Clareon, Clareon Panoptix Pro, Precision7 |
| Tarsus Pharmaceuticals, INC. | $377.26 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $353.71 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Biotissue Holdings INC. | $334.59 | 2023-2024 | |
| Sight Sciences, INC. | $212.28 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $163.54 | 2023-2024 | Tecnis Iol, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $145.37 | 2023-2024 | Cequa |
| Ocular Therapeutix, INC. | $117.79 | 2024 | Dextenza |
| Novartis Pharmaceuticals Corporation | $112.41 | 2019 | |
| Allergan, INC. | $109.32 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $103.15 | 2025 | Neffy |
| E.R. Squibb & Sons, L.L.C. | $81.13 | 2023-2024 | Opdivo, Reblozyl |
| Dompe US, INC. | $78.64 | 2024-2025 | Oxervate |
| Harrow Eye, LLC | $67.58 | 2024-2025 | Triesence, Vevye, Iheezo |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $56.61 | 2025 | Omidria, Rayone Spheric, Rayone Aspheric |
| Glaukos Corporation | $51.08 | 2023-2025 | Idosetr, Istent Infinite |
| Lexicon Pharmaceuticals, INC. | $35.00 | 2023 | Inpefa |
| Optos, INC. | $33.36 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ani Pharmaceuticals, INC. | $33.11 | 2025 | Purified Cortrophin Gel |
| Pacira Pharmaceuticals Incorporated | $26.83 | 2025 | Exparel |
| Lilly USA, LLC | $26.79 | 2024 | Mounjaro |
| Haag-Streit USA, INC. | $25.00 | 2025 | |
| Thea Pharma INC. | $18.78 | 2025 | Iyuzeh |
| Shire North American Group INC | $18.10 | 2019 | |
| New World Medical,INC. | $11.15 | 2024 | Ahmed Glaucoma Valve, Streamline, Clearpath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.